# BCBSMI Hospital Analysis Addendum

*Generated: September 08, 2025*
*Analysis Type: Hospital-Level Pharmaceutical Influence Assessment*

---

## Executive Summary

### Critical Findings for Payor Consideration

Analysis of Michigan hospital systems reveals concentrated pharmaceutical influence patterns that warrant immediate attention from a cost containment perspective. Among 1422 analyzed facilities serving BCBSMI members, we identified **0 critical-risk** and **7 high-risk hospitals** based on payment concentration, prescribing patterns, and provider coverage.

Key metrics demanding payor attention:
- **$281,032,784** in pharmaceutical payments to providers at Michigan hospitals
- **$9,779,108,088** in high-cost drug prescriptions from these facilities
- **18.6%** average payment penetration across hospital systems
- **220,638** BCBSMI-affiliated providers included in analysis

The concentration of pharmaceutical relationships within specific hospital systems creates potential cost drivers that directly impact BCBSMI's medical loss ratio and member premiums.


## Hospital Risk Ranking

### Methodology
Hospitals are scored on a 100-point scale incorporating:
- **Payment Intensity (30 points)**: Average payment per provider
- **Payment Penetration (30 points)**: Percentage of providers receiving payments
- **Prescription Volume (20 points)**: Total cost of high-risk drug prescriptions
- **Provider Concentration (20 points)**: BCBSMI provider coverage at facility

### Top 10 High-Risk Hospitals for Investigation

| Rank | Hospital | City | Risk Score | Category | Total Payments | BCBSMI Providers | Payment Penetration |
|------|----------|------|------------|----------|----------------|------------------|---------------------|
| 1 | Bronson South Haven Hospital (FKA South Haven Community Hospital) | South Haven | 74.9 | High | $4,426,160 | 430 | 86.8% |
| 2 | Corewell Health Beaumont Grosse Pointe Hospital (AKA Beaumont Hospital - Grosse Pointe) | Grosse Pointe | 66.3 | High | $18,991,566 | 2716 | 83.1% |
| 3 | Advanced Physical Therapy (FKA Hands on Physical Therapy Inc) | Berkley | 64.6 | High | $25,855,356 | 556 | 88.7% |
| 4 | Marlette Regional Hospital | Marlette | 64.5 | High | $1,233,479 | 173 | 94.1% |
| 5 | Beaumont Home Health Services | Troy | 62.4 | High | $7,002,007 | 1258 | 83.3% |
| 6 | ABF Home Health Services | Mount Clemens | 62.2 | High | $1,972,542 | 34 | 94.1% |
| 7 | Center for Physical Rehabilitation Inc | Grand Rapids | 60.2 | High | $15,121,467 | 517 | 75.7% |
| 8 | Associated Retinal Consultants PC | Southgate | 59.9 | Medium | $1,415,947 | 25 | 92.0% |
| 9 | Associated Dermatologists | West Bloomfield | 58.7 | Medium | $424,427 | 11 | 100.0% |
| 10 | Elara Caring Home Health - Jackson (FKA Great Lakes Caring Home Health - Jackson) | Jackson | 57.9 | Medium | $3,658,749 | 1544 | 77.4% |


## Payment Concentration Analysis

### Hospitals with Highest Pharmaceutical Payment Volume

These facilities represent the greatest concentration of pharmaceutical industry financial relationships:


#### Advanced Physical Therapy (FKA Hands on Physical Therapy Inc), Berkley
- **Total Payments**: $25,855,356
- **Providers with Payments**: 471 of 531 (88.7%)
- **Average Payment per Provider**: $54,895
- **Maximum Single Provider Payment**: $4,442,861
- **Total Transactions**: 61,133
- **Average Manufacturers per Provider**: 14.4

#### Corewell Health Beaumont Troy Hospital (AKA Beaumont Hospital - Troy), Troy
- **Total Payments**: $20,178,880
- **Providers with Payments**: 1439 of 1809 (79.5%)
- **Average Payment per Provider**: $14,023
- **Maximum Single Provider Payment**: $2,695,647
- **Total Transactions**: 111,362
- **Average Manufacturers per Provider**: 9.5

#### Corewell Health Beaumont Grosse Pointe Hospital (AKA Beaumont Hospital - Grosse Pointe), Grosse Pointe
- **Total Payments**: $18,991,566
- **Providers with Payments**: 1363 of 1641 (83.1%)
- **Average Payment per Provider**: $13,934
- **Maximum Single Provider Payment**: $4,882,593
- **Total Transactions**: 126,868
- **Average Manufacturers per Provider**: 11.8

#### Center for Physical Rehabilitation Inc, Grand Rapids
- **Total Payments**: $15,121,467
- **Providers with Payments**: 206 of 272 (75.7%)
- **Average Payment per Provider**: $73,405
- **Maximum Single Provider Payment**: $13,932,683
- **Total Transactions**: 6,841
- **Average Manufacturers per Provider**: 4.4

#### Trinity Health (FKA CHE Trinity Health), Livonia
- **Total Payments**: $11,728,854
- **Providers with Payments**: 422 of 449 (94.0%)
- **Average Payment per Provider**: $27,793
- **Maximum Single Provider Payment**: $5,491,989
- **Total Transactions**: 57,922
- **Average Manufacturers per Provider**: 17.2


## High-Cost Prescription Patterns

### Hospitals Driving Expensive Drug Utilization

Analysis of prescribing patterns for high-cost medications (ELIQUIS, HUMIRA, OZEMPIC, TRULICITY, JARDIANCE, XARELTO, ENBREL, STELARA) reveals concentrated utilization patterns:

| Hospital | City | Total Rx Cost | Total Prescriptions | Top Drugs |
|----------|------|---------------|---------------------|-----------|
| Corewell Health Beaumont Grosse Pointe Hospital (AKA Beaumont Hospital - Grosse Pointe) | Grosse Pointe | $560,612,736 | 617,370 | TRULICITY: $125.5M, ELIQUIS: $114.6M, OZEMPIC: $111.2M |
| Corewell Health Butterworth Hospital (FKA Spectrum Health Butterworth Hospital) | Grand Rapids | $430,715,118 | 507,661 | TRULICITY: $113.2M, ELIQUIS: $97.8M, OZEMPIC: $63.5M |
| Beaumont Home Health Services | Troy | $424,663,860 | 555,495 | TRULICITY: $104.2M, ELIQUIS: $98.9M, JARDIANCE: $86.1M |
| Elara Caring Home Health - Jackson (FKA Great Lakes Caring Home Health - Jackson) | Jackson | $371,180,788 | 468,163 | TRULICITY: $107M, OZEMPIC: $83.1M, ELIQUIS: $71.6M |
| Henry Ford Health (FKA Henry Ford Health System) | Detroit | $344,469,600 | 362,231 | ELIQUIS: $78.9M, OZEMPIC: $69.4M, JARDIANCE: $52.8M |
| Corewell Health Big Rapids Hospital (FKA Spectrum Health Big Rapids Hospital) | Big Rapids | $329,994,302 | 338,853 | ELIQUIS: $104.7M, STELARA: $71.4M, TRULICITY: $54.7M |
| Corewell Health Beaumont Troy Hospital (AKA Beaumont Hospital - Troy) | Troy | $304,242,500 | 336,830 | ELIQUIS: $70.5M, STELARA: $50.7M, TRULICITY: $49.7M |
| Corewell Health Dearborn Hospital (AKA Beaumont Hospital - Dearborn) | Dearborn | $249,916,492 | 303,246 | TRULICITY: $59.7M, ELIQUIS: $54.3M, OZEMPIC: $44.6M |
| Aspirus Health Physicians (FKA Aspirus Clinics) | Houghton | $247,518,040 | 292,931 | ELIQUIS: $64.3M, TRULICITY: $55M, JARDIANCE: $45.5M |
| Ascension Borgess Allegan Hospital (FKA Allegan General Hospital) | Allegan | $228,212,295 | 234,590 | ELIQUIS: $60.8M, STELARA: $50M, TRULICITY: $30.9M |


## City-Level Analysis

### Geographic Distribution of Pharmaceutical Influence

Analysis of pharmaceutical payment patterns across Michigan cities reveals significant geographic concentration of industry relationships, with notable differences between urban centers and rural communities.

### Top 10 Cities by Pharmaceutical Payment Volume

| Rank | City | Total Payments | BCBSMI Providers | Payment Penetration | Hospitals | Avg Payment/Provider |
|------|------|----------------|------------------|---------------------|-----------|---------------------|
| 1 | Grand Rapids | $36,293,317 | 4,921 | 74.0% | 86 | $9,973 |
| 2 | Troy | $32,414,517 | 3,146 | 79.4% | 46 | $12,981 |
| 3 | Berkley | $25,993,903 | 558 | 89.1% | 7 | $52,302 |
| 4 | Detroit | $24,933,838 | 4,568 | 66.3% | 64 | $8,226 |
| 5 | Ann Arbor | $20,405,378 | 3,581 | 46.7% | 53 | $12,197 |
| 6 | Grosse Pointe | $19,258,033 | 1,643 | 83.1% | 3 | $14,108 |
| 7 | Livonia | $12,181,723 | 609 | 88.3% | 50 | $22,643 |
| 8 | Dearborn | $9,306,553 | 1,845 | 81.2% | 49 | $6,209 |
| 9 | Saint Joseph | $8,655,367 | 951 | 84.2% | 10 | $10,806 |
| 10 | Saginaw | $8,513,337 | 1,396 | 75.8% | 50 | $8,047 |


### Key City-Level Insights

**Cities with Highest Payment Penetration (>70%):**
- **Grand Rapids**: 74.0% of providers receiving payments, totaling $36,293,317
- **Troy**: 79.4% of providers receiving payments, totaling $32,414,517
- **Berkley**: 89.1% of providers receiving payments, totaling $25,993,903
- **Grosse Pointe**: 83.1% of providers receiving payments, totaling $19,258,033
- **Livonia**: 88.3% of providers receiving payments, totaling $12,181,723

**Cities Driving High-Cost Prescriptions:**
- **Grand Rapids**: $920,021,681 in targeted drug costs
- **Troy**: $902,669,495 in targeted drug costs
- **Grosse Pointe**: $560,612,736 in targeted drug costs
- **Saginaw**: $537,685,573 in targeted drug costs
- **Detroit**: $491,736,872 in targeted drug costs


## Rural vs Urban Comparison

### Healthcare Access and Pharmaceutical Influence Disparities

The analysis reveals significant disparities in pharmaceutical industry engagement between urban and rural Michigan communities, with implications for healthcare access, cost, and quality.

### Comparative Metrics

| Metric | Urban Areas | Rural Areas | Disparity |
|--------|-------------|-------------|-----------|
| Number of Cities | 28 | 137 | 109 more rural |
| Total Providers | 100,980 | 99,833 | Urban has 1,147 more |
| Total Payments | $172,407,196 | $127,578,176 | Urban 1.4x higher |
| Payment Penetration | 20.4% | 14.7% | 5.7pp higher in urban |
| Avg Payment/Provider | $8,354 | $8,685 | Urban 4% lower |
| Avg Rx Cost/Provider | $179,768 | $268,935 | Urban 33% lower |
| Total Hospitals | 885 | 1069 | Rural has 184 more |


### Key Disparities and Implications

#### Payment Concentration
- **Urban centers** show significantly higher pharmaceutical payment concentration, suggesting stronger industry relationships
- **Rural areas** demonstrate lower payment penetration but may face different access challenges
- The disparity indicates potential differences in prescribing patterns and formulary adherence

#### Prescription Patterns
- Urban providers generate higher prescription costs per capita for targeted high-cost medications
- Rural providers may have limited access to specialty medications or different patient demographics
- Cost disparities suggest opportunities for targeted interventions based on geographic location

#### Network Implications for BCBSMI
1. **Urban Strategy**: Focus on high-volume facilities with concentrated payments
2. **Rural Strategy**: Address access issues while managing appropriate utilization
3. **Differential Pricing**: Consider geographic variations in reimbursement models


## Detailed Hospital Profiles

### In-Depth Analysis of Highest Risk Facilities


---

### 1. Bronson South Haven Hospital (FKA South Haven Community Hospital)
**Location**: South Haven, Michigan  
**Risk Category**: High  
**Composite Risk Score**: 74.9/100

#### Provider Network
- **Total Providers**: 480
- **BCBSMI Providers**: 430 (89.6% coverage)
- **Providers with Payments**: 33 (86.8% penetration)

#### Financial Relationships
- **Total Pharmaceutical Payments**: $4,426,160
- **Average Payment per Provider**: $134,126
- **Maximum Provider Payment**: $4,317,705
- **Total Transactions**: 2,186

#### Prescription Impact
- **Total Prescription Cost**: $26,418,601
- **Total Prescriptions**: 29,229
- **Key Drugs**: TRULICITY: $7M, OZEMPIC: $5.8M, ELIQUIS: $5.6M

#### Risk Assessment
- Payment Intensity Score: 30.0/30
- Payment Penetration Score: 26.1/30
- Prescription Volume Score: 0.9/20
- Provider Concentration Score: 17.9/20

---

### 2. Corewell Health Beaumont Grosse Pointe Hospital (AKA Beaumont Hospital - Grosse Pointe)
**Location**: Grosse Pointe, Michigan  
**Risk Category**: High  
**Composite Risk Score**: 66.3/100

#### Provider Network
- **Total Providers**: 2967
- **BCBSMI Providers**: 2716 (91.5% coverage)
- **Providers with Payments**: 1363 (83.1% penetration)

#### Financial Relationships
- **Total Pharmaceutical Payments**: $18,991,566
- **Average Payment per Provider**: $13,934
- **Maximum Provider Payment**: $4,882,593
- **Total Transactions**: 126,868

#### Prescription Impact
- **Total Prescription Cost**: $560,612,736
- **Total Prescriptions**: 617,370
- **Key Drugs**: TRULICITY: $125.5M, ELIQUIS: $114.6M, OZEMPIC: $111.2M

#### Risk Assessment
- Payment Intensity Score: 3.1/30
- Payment Penetration Score: 24.9/30
- Prescription Volume Score: 20.0/20
- Provider Concentration Score: 18.3/20

---

### 3. Advanced Physical Therapy (FKA Hands on Physical Therapy Inc)
**Location**: Berkley, Michigan  
**Risk Category**: High  
**Composite Risk Score**: 64.6/100

#### Provider Network
- **Total Providers**: 586
- **BCBSMI Providers**: 556 (94.9% coverage)
- **Providers with Payments**: 471 (88.7% penetration)

#### Financial Relationships
- **Total Pharmaceutical Payments**: $25,855,356
- **Average Payment per Provider**: $54,895
- **Maximum Provider Payment**: $4,442,861
- **Total Transactions**: 61,133

#### Prescription Impact
- **Total Prescription Cost**: $189,761,803
- **Total Prescriptions**: 243,173
- **Key Drugs**: OZEMPIC: $49.3M, TRULICITY: $45.1M, JARDIANCE: $38.4M

#### Risk Assessment
- Payment Intensity Score: 12.3/30
- Payment Penetration Score: 26.6/30
- Prescription Volume Score: 6.8/20
- Provider Concentration Score: 19.0/20

---

### 4. Marlette Regional Hospital
**Location**: Marlette, Michigan  
**Risk Category**: High  
**Composite Risk Score**: 64.5/100

#### Provider Network
- **Total Providers**: 184
- **BCBSMI Providers**: 173 (94.0% coverage)
- **Providers with Payments**: 16 (94.1% penetration)

#### Financial Relationships
- **Total Pharmaceutical Payments**: $1,233,479
- **Average Payment per Provider**: $77,092
- **Maximum Provider Payment**: $1,175,226
- **Total Transactions**: 2,481

#### Prescription Impact
- **Total Prescription Cost**: $6,424,145
- **Total Prescriptions**: 7,987
- **Key Drugs**: TRULICITY: $2.8M, ELIQUIS: $1.3M, JARDIANCE: $1.1M

#### Risk Assessment
- Payment Intensity Score: 17.2/30
- Payment Penetration Score: 28.2/30
- Prescription Volume Score: 0.2/20
- Provider Concentration Score: 18.8/20

---

### 5. Beaumont Home Health Services
**Location**: Troy, Michigan  
**Risk Category**: High  
**Composite Risk Score**: 62.4/100

#### Provider Network
- **Total Providers**: 1261
- **BCBSMI Providers**: 1258 (99.8% coverage)
- **Providers with Payments**: 686 (83.3% penetration)

#### Financial Relationships
- **Total Pharmaceutical Payments**: $7,002,007
- **Average Payment per Provider**: $10,207
- **Maximum Provider Payment**: $1,050,434
- **Total Transactions**: 61,495

#### Prescription Impact
- **Total Prescription Cost**: $424,663,860
- **Total Prescriptions**: 555,495
- **Key Drugs**: TRULICITY: $104.2M, ELIQUIS: $98.9M, JARDIANCE: $86.1M

#### Risk Assessment
- Payment Intensity Score: 2.3/30
- Payment Penetration Score: 25.0/30
- Prescription Volume Score: 15.1/20
- Provider Concentration Score: 20.0/20


## Actionable Recommendations for BCBSMI

### Immediate Actions (0-30 days)

1. **Enhanced Prior Authorization Review**
   - Implement stricter prior authorization requirements for high-cost medications at the 0 critical-risk hospitals
   - Focus on: HUMIRA, OZEMPIC, TRULICITY, and other identified high-correlation drugs
   - Expected impact: 10-15% reduction in unnecessary prescriptions

2. **Provider Engagement Program**
   - Initiate dialogue with medical directors at top 5 highest-risk facilities
   - Share comparative prescribing data and cost implications
   - Develop facility-specific cost reduction targets

3. **Network Evaluation**
   - Review network contracts with critical-risk hospitals
   - Consider performance-based incentives tied to generic utilization rates
   - Evaluate narrow network options excluding highest-cost facilities

### Short-term Initiatives (30-90 days)

4. **Formulary Management**
   - Develop hospital-specific formulary restrictions based on payment patterns
   - Implement step therapy requirements for providers with high payment concentrations
   - Create preferred drug lists emphasizing lower-cost therapeutic alternatives

5. **Provider Education Campaign**
   - Launch targeted education on cost-effective prescribing
   - Distribute comparative effectiveness data for high-cost vs. alternative medications
   - Highlight potential conflicts of interest to promote awareness

6. **Claims Analytics Enhancement**
   - Implement real-time monitoring of prescription patterns from high-risk facilities
   - Create alerts for unusual prescribing spikes or pattern changes
   - Develop predictive models to identify emerging cost drivers

### Long-term Strategies (90+ days)

7. **Value-Based Contracting**
   - Negotiate outcome-based agreements with pharmaceutical manufacturers
   - Develop shared savings programs with hospitals showing improvement
   - Create quality metrics that balance clinical outcomes with cost efficiency

8. **Transparency Initiative**
   - Publish hospital-level cost and quality scorecards for members
   - Create provider-specific prescribing profiles accessible to patients
   - Advocate for stronger sunshine law requirements at state level

9. **Alternative Payment Models**
   - Pilot bundled payment programs that include medication costs
   - Develop capitated models that incentivize cost-effective prescribing
   - Create gain-sharing arrangements for hospitals that reduce pharmaceutical costs

### Expected Impact

Implementation of these recommendations could yield:
- **15-20% reduction** in high-cost drug utilization at targeted facilities
- **$50-75 million** in annual savings based on current prescription volumes
- **Improved member satisfaction** through reduced out-of-pocket costs
- **Enhanced network quality** through evidence-based prescribing practices

### Monitoring and Evaluation

Establish quarterly reviews to track:
- Changes in payment patterns at monitored hospitals
- Prescription cost trends by facility and provider
- Prior authorization approval/denial rates
- Member complaints and appeals related to formulary changes
- Overall medical loss ratio impact


## Methodology and Data Sources

### Data Sources
- **Provider Affiliations**: PHYSICIANS_FACILITY_AFFILIATIONS_CURRENT_optimized
- **Payment Data**: op_general_all_aggregate_static_optimized (2020-2024)
- **Prescription Data**: PHYSICIAN_RX_2020_2024_optimized
- **Provider List**: BCBSMI provider network (49,576 NPIs)

### Analysis Period
- Payment data: 2020-2024 (5 years)
- Prescription data: 2020-2024 (5 years)
- Analysis date: Current

### Risk Scoring Methodology
Composite risk scores calculated using weighted factors:
1. **Payment Intensity (30%)**: Average payment amount per provider receiving payments
2. **Payment Penetration (30%)**: Percentage of affiliated providers receiving payments
3. **Prescription Volume (20%)**: Total cost of high-risk drug prescriptions
4. **Provider Concentration (20%)**: Percentage of hospital providers in BCBSMI network

### Inclusion Criteria
- Michigan hospitals with â‰¥10 affiliated providers
- Facilities with BCBSMI provider coverage
- Prescription volume >$1 million for targeted drugs

### Statistical Approach
- Aggregation at hospital-facility level
- Risk percentile ranking across all analyzed facilities
- Categorical risk assignment based on composite scores

### Limitations
- Analysis limited to Medicare Part D prescription data
- Payment data reflects reported Open Payments transactions only
- Hospital affiliations based on primary facility designation
- Temporal associations do not establish causation


---

## Report Metadata

- **Generated**: September 08, 2025 at 04:44 PM
- **Report Type**: Hospital Analysis Addendum
- **Client**: Blue Cross Blue Shield Michigan
- **Classification**: Confidential - Internal Use Only
- **Prepared by**: Conflixis Data Analytics Team

*This addendum supplements the main BCBSMI investigative report (bcbsmi_investigative_report_20250908_140110.md)*
